Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Lymphoma

Free Subscription Articles published in Leukemia Retrieve available abstracts of 153 articles: HTML format

Single Articles

May 2008
1. JUNDT F , Acikgoz O, Kwon SH, Schwarzer R, et al
   Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.
   Leukemia. 2008;.
   PubMed     Related articles    Abstract available
   
   
   April 2008
2. RITZ O , Guiter C, Dorsch K, Dusanter-Fourt I, et al
   STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-Cell lymphoma.
   Leukemia. 2008;.
   PubMed     Related articles   
   
   
   March 2008
3. USHMOROV A , Leithauser F, Ritz O, Barth TF, et al
   ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma.
   Leukemia. 2008;.
   PubMed     Related articles   
   
   
   
4. ZHANG T , Nie K, Tam W
   BIC is processed efficiently to microRNA-155 in Burkitt lymphoma cells.
   Leukemia. 2008;.
   PubMed     Related articles   
   
   
   
5. BERNARDESCHI P , Fiorentini G, Dentico P, Rossi S, et al
   Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records.
   Leukemia. 2008;.
   PubMed     Related articles   
   
   
   
6. HAGENBEEK TJ , Spits H
   T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus.
   Leukemia. 2008;22:608-19.
   PubMed     Related articles    Abstract available
   
   
   
7. HENRICH S , Christopherson RI
   Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine.
   Leukemia. 2008;22:657-60.
   PubMed     Related articles   
   
   
   February 2008
8. HIWARKAR P , Arkenau HT, Treleaven J, Morgan G, et al
   The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma.
   Leukemia. 2008;.
   PubMed     Related articles   
   
   
   
9. PIKE BL , Greiner TC, Wang X, Weisenburger DD, et al
   DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status.
   Leukemia. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. MONTESINOS-RONGEN M , Brunn A, Bentink S, Basso K, et al
    Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell.
    Leukemia. 2008;22:400-5.
    PubMed     Related articles    Abstract available
    
    
    January 2008
11. STAMATOPOULOS K , Papadaki T, Pontikoglou C, Athanasiadou I, et al
    Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia.
    Leukemia. 2008;.
    PubMed     Related articles   
    
    
    
12. MATTEUCCI C , Bracci M, Barba G, Carbonari M, et al
    Different genomic imbalances in low- and high-grade HCV-related lymphomas.
    Leukemia. 2008;22:219-22.
    PubMed     Related articles   
    
    
    December 2007
13. MATUTES E , Oscier D, Montalban C, Berger F, et al
    Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
14. HADDAD L , El Hajj H, Abou-Merhi R, Kfoury Y, et al
    KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. TAKAKUWA T , Tresnasari K, Rahadiani N, Miwa H, et al
    Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein-Barr virus infection.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
16. WESSENDORF S , Barth TF, Viardot A, Mueller A, et al
    Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH).
    Leukemia. 2007;21:2463-9.
    PubMed     Related articles    Abstract available
    
    
    
17. HUMENIUK R , Menon LG, Mishra PJ, Saydam G, et al
    Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.
    Leukemia. 2007;21:2399-405.
    PubMed     Related articles    Abstract available
    
    
    
18. GJERDRUM LM , Woetmann A, Odum N, Burton CM, et al
    FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
    Leukemia. 2007;21:2512-8.
    PubMed     Related articles    Abstract available
    
    
    
19. RUIZ-BALLESTEROS E , Mollejo M, Mateo M, Algara P, et al
    MicroRNA losses in the frequently deleted region of 7q in SMZL.
    Leukemia. 2007;21:2547-9.
    PubMed     Related articles   
    
    
    
20. REDDICONTO G , Chiusolo P, Fiorini A, Farina G, et al
    Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation.
    Leukemia. 2007;21:2552-4.
    PubMed     Related articles   
    
    
    
21. PORRATA LF , Ristow K, Witzig TE, Tuinistra N, et al
    Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas.
    Leukemia. 2007;21:2554-6.
    PubMed     Related articles   
    
    
    November 2007
22. BOOKEN N , Gratchev A, Utikal J, Weiss C, et al
    Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. KRATZ CP , Niemeyer CM, Juttner E, Kartal M, et al
    Childhood T-cell non-Hodgkin's lymphoma, colorectal carcinoma and brain tumor in association with cafe-au-lait spots caused by a novel homozygous PMS2 mutation.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
24. REMSTEIN ED , Law M, Mollejo M, Piris MA, et al
    The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
25. NAGEL S , Leich E, Quentmeier H, Meyer C, et al
    Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. SANDA T , Okamoto T, Uchida Y, Nakagawa H, et al
    Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells.
    Leukemia. 2007;21:2344-53.
    PubMed     Related articles    Abstract available
    
    
    
27. OSTROVSKY O , Korostishevsky M, Levite I, Leiba M, et al
    Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
    Leukemia. 2007;21:2296-303.
    PubMed     Related articles    Abstract available
    
    
    
28. CORRADINI P , Dodero A, Farina L, Fanin R, et al
    Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome.
    Leukemia. 2007;21:2316-23.
    PubMed     Related articles    Abstract available
    
    
    October 2007
29. LORENZO BERMEJO J , Sundquist J, Hemminki K
    Effect of parental history of cancer on the development of second neoplasms after lymphoma at the same site than the parents.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
30. SHVIDEL L , Sigler E, Vorst E, Feldberg E, et al
    A novel cytogenetic aberration found in stem cell leukemia/lymphoma syndrome.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
31. NIEMANN CU , Kjeldsen L, Ralfkiaer E, Jensen MK, et al
    Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
32. HERREROS B , Sanchez-Aguilera A, Piris MA
    Lymphoma microenvironment: culprit or innocent?
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. DINGLI D , Russell SJ
    Mouse models and the RANKL/OPG axis in myeloma bone disease.
    Leukemia. 2007;21:2090-3.
    PubMed     Related articles   
    
    
    
34. RABIN N , Kyriakou C, Coulton L, Gallagher OM, et al
    A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer.
    Leukemia. 2007;21:2181-91.
    PubMed     Related articles    Abstract available
    
    
    
35. GUIDOLIN D , Nico B, Belloni AS, Nussdorfer GG, et al
    Morphometry and mathematical modelling of the capillary-like patterns formed in vitro by bone marrow macrophages of patients with multiple myeloma.
    Leukemia. 2007;21:2201-3.
    PubMed     Related articles   
    
    
    September 2007
36. WANG M , Han XH, Zhang L, Yang J, et al
    Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. ZHAO S , Tang QL, He MX, Yang F, et al
    A novel nude mice model of human extranodal nasal type NK/T-cell lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. ROY JS , Van Themsche C, Demers M, Opdenakker G, et al
    Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. DE TUTE RM , Jack AS, Child JA, Morgan GJ, et al
    A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma.
    Leukemia. 2007;21:2046-9.
    PubMed     Related articles   
    
    
    
40. GOLAY J , Cuppini L, Leoni F, Mico C, et al
    The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells.
    Leukemia. 2007;21:1892-900.
    PubMed     Related articles    Abstract available
    
    
    
41. MOREAU P , Attal M, Garban F, Hulin C, et al
    Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials.
    Leukemia. 2007;21:2020-4.
    PubMed     Related articles    Abstract available
    
    
    
42. TERPOS E , Dimopoulos MA, Sezer O
    The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma.
    Leukemia. 2007;21:1875-84.
    PubMed     Related articles    Abstract available
    
    
    
43. KUMAR S , Dispenzieri A, Lacy MQ, Hayman SR, et al
    Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma.
    Leukemia. 2007;21:2035-42.
    PubMed     Related articles    Abstract available
    
    
    
44. VON METZLER I , Krebbel H, Hecht M, Manz RA, et al
    Bortezomib inhibits human osteoclastogenesis.
    Leukemia. 2007;21:2025-34.
    PubMed     Related articles    Abstract available
    
    
    
45. KROGER N
    Mini-Midi-Maxi? How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation.
    Leukemia. 2007;21:1851-8.
    PubMed     Related articles    Abstract available
    
    
    
46. POSPISILOVA H , Baens M, Michaux L, Stul M, et al
    Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL.
    Leukemia. 2007;21:2079-83.
    PubMed     Related articles   
    
    
    
47. MONNEREAU A , Orsi L, Troussard X, Berthou C, et al
    History of infections and vaccinations and risk of lymphoid neoplasms: does influenza immunization reduce the risk?
    Leukemia. 2007;21:2075-9.
    PubMed     Related articles   
    
    
    August 2007
48. TAYLOR KH , Rahmatpanah F, Davis JW, Caldwell CW, et al
    Chromosomal localization of DNA methylation in small B-cell lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
49. DIAZ Z , Laurenzana A, Mann KK, Bismar TA, et al
    Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. TRAVERSE-GLEHEN A , Verney A, Baseggio L, Felman P, et al
    Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.
    Leukemia. 2007;21:1821-4.
    PubMed     Related articles   
    
    
    July 2007
51. ABUBAKER J , Bavi PP, Al-Harbi S, Siraj AK, et al
    PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
52. MONTOTO S , Canals C, Rohatiner AZ, Taghipour G, et al
    Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
53. IQBAL J , Greiner TC, Patel K, Dave BJ, et al
    Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. TAGAWA H , Karube K, Guo Y, Takeshita M, et al
    Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
55. MARTIN-SUBERO JI , Ibbotson R, Klapper W, Michaux L, et al
    A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation.
    Leukemia. 2007;21:1532-44.
    PubMed     Related articles    Abstract available
    
    
    
56. PARK S , Borderie D, Cormier C, Bouscary D, et al
    Effect of spacing intravenous bisphosphonates in patients with multiple myeloma in plateau phase.
    Leukemia. 2007;21:1596-9.
    PubMed     Related articles   
    
    
    
57. KLINE MP , Rajkumar SV, Timm MM, Kimlinger TK, et al
    ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells.
    Leukemia. 2007;21:1549-60.
    PubMed     Related articles    Abstract available
    
    
    
58. CORSO A , Varettoni M, Zappasodi P, Klersy C, et al
    A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma.
    Leukemia. 2007;21:1545-8.
    PubMed     Related articles    Abstract available
    
    
    
59. CHANG H , Qi Q, Xu W, Patterson B, et al
    c-Maf nuclear oncoprotein is frequently expressed in multiple myeloma.
    Leukemia. 2007;21:1572-4.
    PubMed     Related articles   
    
    
    
60. CAERS J , Deleu S, Belaid Z, De Raeve H, et al
    Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells.
    Leukemia. 2007;21:1580-4.
    PubMed     Related articles   
    
    
    June 2007
61. SAITO B , Shiozawa E, Usui T, Nakashima H, et al
    Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
62. ABOU-MERHI R , Khoriaty R, Arnoult D, El Hajj H, et al
    PS-341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. KIM DH , Baek JH, Chae YS, Kim YK, et al
    Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
64. TARELLA C , Zanni M, Di Nicola M, Patti C, et al
    Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italia
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. WOHRER S , Troch M, Streubel B, Zwerina J, et al
    MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. STORLAZZI CT , Albano F, Lo Cunsolo C, Doglioni C, et al
    Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
67. NADELLA MV , Dirksen WP, Nadella KS, Shu S, et al
    Transcriptional regulation of parathyroid hormone-related protein promoter P2 by NF-kappaB in adult T-cell leukemia/lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. ODY C , Jungblut-Ruault S, Cossali D, Barnet M, et al
    Junctional adhesion molecule C (JAM-C) distinguishes CD27+ germinal center B lymphocytes from non-germinal center cells and constitutes a new diagnostic tool for B-cell malignancies.
    Leukemia. 2007;21:1285-93.
    PubMed     Related articles    Abstract available
    
    
    
69. BREITKREUTZ I , Lokhorst HM, Raab MS, Holt B, et al
    Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield.
    Leukemia. 2007;21:1294-9.
    PubMed     Related articles    Abstract available
    
    
    
70. MIHELIC R , Kaufman JL, Lonial S
    Maintenance therapy in multiple myeloma.
    Leukemia. 2007;21:1150-7.
    PubMed     Related articles    Abstract available
    
    
    
71. SCHWALLER J , Went P, Matthes T, Dirnhofer S, et al
    Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease.
    Leukemia. 2007;21:1324-7.
    PubMed     Related articles   
    
    
    May 2007
72. BUSCH K , Keller T, Fuchs U, Yeh RF, et al
    Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. TSE E , Chan JC, Pang A, Au WY, et al
    Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
74. FITZGIBBON J , Iqbal S, Davies A, O'shea D, et al
    Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. STAMATOULLAS A , Picquenot JM, Dumesnil C, Ruminy P, et al
    Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
76. KNOP S , Hebart H, Gratwohl A, Kliem C, et al
    Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
77. LWIN T , Hazlehurst LA, Li Z, Dessureault S, et al
    Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. CLAUDIO JO , Zhan F, Zhuang L, Khaja R, et al
    Expression and mutation status of candidate kinases in multiple myeloma.
    Leukemia. 2007;21:1124-7.
    PubMed     Related articles   
    
    
    
79. CORRE J , Mahtouk K, Attal M, Gadelorge M, et al
    Bone marrow mesenchymal stem cells are abnormal in multiple myeloma.
    Leukemia. 2007;21:1079-88.
    PubMed     Related articles    Abstract available
    
    
    
80. ROMAGNOLI M , Trichet V, David C, Clement M, et al
    Significant impact of survivin on myeloma cell growth.
    Leukemia. 2007;21:1070-8.
    PubMed     Related articles    Abstract available
    
    
    
81. FABRIS S , Ronchetti D, Agnelli L, Baldini L, et al
    Transcriptional features of multiple myeloma patients with chromosome 1q gain.
    Leukemia. 2007;21:1113-6.
    PubMed     Related articles   
    
    
    April 2007
82. HIRAGA J , Katsumi A, Iwasaki T, Abe A, et al
    Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
83. LIN YW , Aplan PD
    Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. YAMASAKI R , Miyazaki Y, Moriuchi Y, Tsutsumi C, et al
    Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. RENNE C , Willenbrock K, Martin-Subero JI, Hinsch N, et al
    High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma.
    Leukemia. 2007;21:780-7.
    PubMed     Related articles    Abstract available
    
    
    
86. LOCKLIN RM , Croucher PI, Russell RG, Edwards CM, et al
    Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment.
    Leukemia. 2007;21:805-12.
    PubMed     Related articles    Abstract available
    
    
    
87. RAMIREZ JM , Ocio EM, San Miguel JF, Pandiella A, et al
    Pemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosis.
    Leukemia. 2007;21:797-804.
    PubMed     Related articles    Abstract available
    
    
    
88. PRINCE HM , Schenkel B, Mileshkin L
    Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: a study of bortezomib and thalidomide.
    Leukemia. 2007;21:818-20.
    PubMed     Related articles   
    
    
    
89. MOREAU P , Voillat L, Benboukher L, Mathiot C, et al
    Rituximab in CD20 positive multiple myeloma.
    Leukemia. 2007;21:835-6.
    PubMed     Related articles   
    
    
    
90. JANZ M , Stuhmer T, Vassilev LT, Bargou RC, et al
    Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells.
    Leukemia. 2007;21:772-9.
    PubMed     Related articles    Abstract available
    
    
    
91. HEDENUS M , Birgegard G, Nasman P, Ahlberg L, et al
    Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study.
    Leukemia. 2007;21:627-32.
    PubMed     Related articles    Abstract available
    
    
    
92. HUANG Q , Li X, Chen W, Weiss LM, et al
    Absence of JAK-2V617F point mutations in multiple myeloma.
    Leukemia. 2007;21:813-4.
    PubMed     Related articles   
    
    
    March 2007
93. SUN Y , Ottosson A, Pervaiz S, Fadeel B, et al
    Smac-mediated sensitization of human B-lymphoma cells to staurosporine- and lactacystin-triggered apoptosis is apoptosome-dependent.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
94. METZGEROTH G , Walz C, Score J, Siebert R, et al
    Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
95. ATTARBASCHI A , Mann G, Schumich A, Konig M, et al
    CD44 deficiency is a consistent finding in childhood Burkitt's lymphoma and leukemia.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
96. YASUI H , Hideshima T, Ikeda H, Ocio EM, et al
    Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway.
    Leukemia. 2007;21:535-40.
    PubMed     Related articles    Abstract available
    
    
    
97. STEWART AK , Bergsagel PL, Greipp PR, Dispenzieri A, et al
    A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
    Leukemia. 2007;21:529-34.
    PubMed     Related articles    Abstract available
    
    
    
98. SAGAERT X , De Wolf-Peeters C, Noels H, Baens M, et al
    The pathogenesis of MALT lymphomas: where do we stand?
    Leukemia. 2007;21:389-96.
    PubMed     Related articles    Abstract available
    
    
    
99. BERTRAND P , Bastard C, Maingonnat C, Jardin F, et al
    Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
    Leukemia. 2007;21:515-23.
    PubMed     Related articles    Abstract available
    
    
    
100. POTENZA L , Barozzi P, Vallerini D, Bosco R, et al
     Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates.
     Leukemia. 2007;21:578-81.
     PubMed     Related articles   
     
     
     
101. CHNG WJ , Price-Troska T, Gonzalez-Paz N, Van Wier S, et al
     Clinical significance of TP53 mutation in myeloma.
     Leukemia. 2007;21:582-4.
     PubMed     Related articles   
     
     
     February 2007
102. HU HM , Kanda K, Zhang L, Boxer LM, et al
     Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
     Leukemia. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. WEIGERT O , Pastore A, Rieken M, Lang N, et al
     Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma.
     Leukemia. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
104. BONVINI P , Zorzi E, Basso G, Rosolen A, et al
     Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30(+) anaplastic large cell lymphoma.
     Leukemia. 2007;.
     PubMed     Related articles   
     
     
     
105. EVANS PA , Pott Ch, Groenen PJ, Salles G, et al
     Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.
     Leukemia. 2007;21:207-14.
     PubMed     Related articles    Abstract available
     
     
     
106. BRUGGEMANN M , White H, Gaulard P, Garcia-Sanz R, et al
     Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936.
     Leukemia. 2007;21:215-21.
     PubMed     Related articles    Abstract available
     
     
     
107. PILERI SA , Ascani S, Cox MC, Campidelli C, et al
     Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients.
     Leukemia. 2007;21:340-50.
     PubMed     Related articles    Abstract available
     
     
     January 2007
108. GUTIERREZ NC , Ocio EM, de Las Rivas J, Maiso P, et al
     Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
     Leukemia. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
109. DISPENZIERI A
     An internationally recognized uniform cytogenetic classification system is needed for multiple myeloma.
     Leukemia. 2007;21:9-11.
     PubMed     Related articles   
     
     
     
110. KARAGIANNIS TC , El-Osta A
     Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?
     Leukemia. 2007;21:61-5.
     PubMed     Related articles    Abstract available
     
     
     
111. JAGANNATH S , Richardson PG, Sonneveld P, Schuster MW, et al
     Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials.
     Leukemia. 2007;21:151-7.
     PubMed     Related articles    Abstract available
     
     
     
112. NENCIONI A , Grunebach F, Patrone F, Ballestrero A, et al
     Proteasome inhibitors: antitumor effects and beyond.
     Leukemia. 2007;21:30-6.
     PubMed     Related articles    Abstract available
     
     
     
113. SAGASTER V , Ludwig H, Kaufmann H, Odelga V, et al
     Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion.
     Leukemia. 2007;21:164-8.
     PubMed     Related articles    Abstract available
     
     
     
114. ARNULF B , Lecourt S, Soulier J, Ternaux B, et al
     Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma.
     Leukemia. 2007;21:158-63.
     PubMed     Related articles    Abstract available
     
     
     
115. ZUO Y , Wei W, Liu C, Zhao L, et al
     Silencing L-selectin expression by siRNA attenuated metastasis of murine lymphoid neoplasm cell P388D1 to peripheral lymph nodes.
     Leukemia. 2007;21:180-3.
     PubMed     Related articles   
     
     
     
116. OTSUYAMA KI , Ma Z, Abroun S, Amin J, et al
     PPARbeta-mediated growth suppression of baicalein and dexamethasone in human myeloma cells.
     Leukemia. 2007;21:187-90.
     PubMed     Related articles   
     
     
     
117. MAGGINI V , Buda G, Galimberti S, Conidi E, et al
     Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation.
     Leukemia. 2007;21:176-8.
     PubMed     Related articles   
     
     
     
118. GUTIERREZ NC , Castellanos MV, Martin ML, Mateos MV, et al
     Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated
     Leukemia. 2007;21:143-50.
     PubMed     Related articles    Abstract available
     
     
     December 2006
119. VAN KRIEKEN JH , Langerak AW, Macintyre EA, Kneba M, et al
     Improved reliability of lymphoma diagnostics via PCR-based clonality testing: - Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.
     Leukemia. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
120. HORWITZ MS , Mealiffe ME
     Further evidence for a pseudoautosomal gene for Hodgkin's lymphoma: Reply to 'The familial risk of Hodgkin's lymphoma ranks among the highest in the Swedish Family-Cancer Database' by Altieri A and Hemminki K.
     Leukemia. 2006;.
     PubMed     Related articles   
     
     
     November 2006
121. HARITUNIANS T , Mori A, O'kelly J, Luong QT, et al
     Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma.
     Leukemia. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
122. FONSECA R , Van Wier SA, Chng WJ, Ketterling R, et al
     Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma.
     Leukemia. 2006;20:2034-40.
     PubMed     Related articles    Abstract available
     
     
     October 2006
123. ISE T , Nagata S, Kreitman RJ, Wilson WH, et al
     Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma.
     Leukemia. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
124. ISHIDA T , Ishii T, Inagaki A, Yano H, et al
     The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma.
     Leukemia. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
125. BENDE RJ , Smit LA, van Noesel CJ
     Molecular pathways in follicular lymphoma.
     Leukemia. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
126. DE PAEPE P , De Wolf-Peeters C
     Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities.
     Leukemia. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
127. COOPER CD , Liggins AP, Ait-Tahar K, Roncador G, et al
     PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy.
     Leukemia. 2006;.
     PubMed     Related articles   
     
     
     
128. MARTIN-SUBERO JI , Ballestar E, Esteller M, Siebert R, et al
     Towards defining the lymphoma methylome.
     Leukemia. 2006;20:1658-60.
     PubMed     Related articles   
     
     
     
129. NUMBENJAPON T , Serrano LM, Singh H, Kowolik CM, et al
     Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells.
     Leukemia. 2006;20:1889-92.
     PubMed     Related articles   
     
     
     
130. TIMM MM , Kimlinger TK, Haug JL, Kline MP, et al
     Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma.
     Leukemia. 2006;20:1863-9.
     PubMed     Related articles    Abstract available
     
     
     
131. DE BRUYNE E , Andersen TL, De Raeve H, Van Valckenborgh E, et al
     Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients.
     Leukemia. 2006;20:1870-9.
     PubMed     Related articles    Abstract available
     
     
     
132. TAYLOR KH , Liu J, Guo J, Davis JW, et al
     Promoter DNA methylation of CD10 in lymphoid malignancies.
     Leukemia. 2006;20:1910-2.
     PubMed     Related articles   
     
     
     
133. BENSINGER WI
     The current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma.
     Leukemia. 2006;20:1683-9.
     PubMed     Related articles    Abstract available
     
     
     
134. EINERSON RR , Law ME, Blair HE, Kurtin PJ, et al
     Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2.
     Leukemia. 2006;20:1790-9.
     PubMed     Related articles    Abstract available
     
     
     
135. FIORINI A , Farina G, Reddiconto G, Palladino M, et al
     Screening of JAK2 V617F mutation in multiple myeloma.
     Leukemia. 2006;20:1912-3.
     PubMed     Related articles   
     
     
     September 2006
136. MODIANO JF , Breen M, Valli VE, Wojcieszyn JW, et al
     Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lymphoma.
     Leukemia. 2006;.
     PubMed     Related articles   
     
     
     
137. JARDIN F , Sahota SS, Ruminy P, Parmentier F, et al
     Novel Ig V gene features of t(14;18) and t(3;14) de novo diffuse large B-cell lymphoma displaying germinal center-B cell like and non-germinal center-B cell like markers.
     Leukemia. 2006;.
     PubMed     Related articles   
     
     
     
138. ZHAN F , Sawyer J, Tricot G
     The role of cytogenetics in myeloma.
     Leukemia. 2006;20:1484-6.
     PubMed     Related articles   
     
     
     
139. CORRADINI P , Tarella C, Zallio F, Dodero A, et al
     Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation.
     Leukemia. 2006;20:1533-8.
     PubMed     Related articles    Abstract available
     
     
     
140. DURIE BG , Harousseau JL, Miguel JS, Blade J, et al
     International uniform response criteria for multiple myeloma.
     Leukemia. 2006;20:1467-73.
     PubMed     Related articles    Abstract available
     
     
     
141. RINGROSE A , Zhou Y, Pang E, Zhou L, et al
     Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas.
     Leukemia. 2006;20:1593-601.
     PubMed     Related articles    Abstract available
     
     
     
142. CHIECCHIO L , Protheroe RK, Ibrahim AH, Cheung KL, et al
     Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma.
     Leukemia. 2006;20:1610-7.
     PubMed     Related articles    Abstract available
     
     
     August 2006
143. ALTIERI A , Hemminki K
     The familial risk of Hodgkin's lymphoma ranks among the highest in the Swedish Family-Cancer Database.
     Leukemia. 2006;.
     PubMed     Related articles   
     
     
     June 2006
144. MANTOVANI A , Garlanda C
     Inflammation and multiple myeloma: the Toll connection.
     Leukemia. 2006;20:937-8.
     PubMed     Related articles   
     
     
     
145. JEGO G , Bataille R, Geffroy-Luseau A, Descamps G, et al
     Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors.
     Leukemia. 2006;20:1130-7.
     PubMed     Related articles    Abstract available
     
     
     
146. NAVAS TA , Nguyen AN, Hideshima T, Reddy M, et al
     Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.
     Leukemia. 2006;20:1017-27.
     PubMed     Related articles    Abstract available
     
     
     
147. DE RE V , Sansonno D, Simula MP, Caggiari L, et al
     HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations.
     Leukemia. 2006;20:1145-54.
     PubMed     Related articles    Abstract available
     
     
     
148. BOHNHORST J , Rasmussen T, Moen SH, Flottum M, et al
     Toll-like receptors mediate proliferation and survival of multiple myeloma cells.
     Leukemia. 2006;20:1138-44.
     PubMed     Related articles    Abstract available
     
     
     
149. KREJCI P , Mekikian PB, Wilcox WR
     The fibroblast growth factors in multiple myeloma.
     Leukemia. 2006;20:1165-8.
     PubMed     Related articles   
     
     
     
150. CHIM CS , Liang R, Leung MH, Yip SF, et al
     Aberrant gene promoter methylation marking disease progression in multiple myeloma.
     Leukemia. 2006;20:1190-2.
     PubMed     Related articles   
     
     
     
151. YING J , Li H, Cui Y, Wong AH, et al
     Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter.
     Leukemia. 2006;20:1173-5.
     PubMed     Related articles   
     
     
     
152. BASECKE J , Karim K, Podleschny M, Becker A, et al
     MLL rearrangements emerge during spontaneous apoptosis of clinical blood samples.
     Leukemia. 2006;20:1193-4.
     PubMed     Related articles   
     
     
     
153. KLEMKE CD , Fritzsching B, Franz B, Kleinmann EV, et al
     Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas.
     Leukemia. 2006;20:1123-9.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: